C C Stock

891 citations
5 papers · 709 · 1 hit paper · h-index 5

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Ion Transport and Channel Regulation
    • RNA Interference and Gene Delivery
    • Cancer therapeutics and mechanisms

Papers in

    • Ion Transport and Channel Regulation 2
    • Ion channel regulation and function 2
    • Cancer therapeutics and mechanisms 1
    • Pancreatic function and diabetes 1

C C Stock

5 papers receiving 685 citations

C C Stock's Hit Papers

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp 2015 · 513 citations
5130+3+7Years since publication100200300400500

Peers

C C Stock
Comparison fields: 5 of 89
  • Cancer Research 127
  • Molecular Biology 398
  • Biomaterials 78
  • Oncology 143
  • Toxicology 16
Replace Shoujun Yuan with:
Shoujun Yuan China
Saifuddin Sheikh India
Jayant Dewangan India
Abdel Khalig Muddathir Sudan
ŞERBAN COMŞA Romania
Aneta Koceva‐Chyła Poland
J. C. Maurizis France
Eva Calviño Spain
Ateeq Ahmad India
Aykut Özgür Türkiye
C C Stock relative to Shoujun Yuan China Shoujun Yuan's profile →
Citations per field
00.5×1.5×
Shoujun Yuan · 1×
Citations per year

Countries citing papers authored by C C Stock

Since Specialization
Citations

This map shows the geographic impact of C C Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C C Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C C Stock more than expected).

Fields of papers citing papers by C C Stock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C C Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C C Stock. The network helps show where C C Stock may publish in the future.

Co-authors

The 19 scholars most cited alongside C C Stock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C C Stock Line = papers co-authored together C C Stock links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Hit paper breakdown →
2015513
2 201195
3
Tumor inhibitors in Boletus edulis and other Holobasidiomycetes.
195766
4 201230
5
Effects of compounds on the Friend mouse virus leukemia.
19605

About C C Stock

C C Stock is a scholar working on Molecular Biology, Surgery, Small Animals, Pharmacology and Oncology, having authored 5 papers that have together received 709 indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (2 papers), Ion channel regulation and function (2 papers), Infectious Diseases and Mycology (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Adenosine and Purinergic Signaling (1 paper), Fungal Biology and Applications (1 paper), Cancer therapeutics and mechanisms (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cancer Research (127 citations), Molecular Biology (398 citations), Biomaterials (78 citations), Oncology (143 citations) and Toxicology (16 citations). C C Stock has collaborated with scholars based in Germany, Italy and Saudi Arabia. Frequent co-authors include Khalid O. Alfarouk, Stephan J. Reshkin, Cyril Rauch, Sophie Taylor, Salvador Harguindey, Daniel Verduzco, Gamal Osman Elhassan, Abdel Khalig Muddathir, Muntaser E. Ibrahim and Adil H. H. Bashir. Their work appears in journals such as Cancer Letters, Cancer Cell International, Current Medicinal Chemistry and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact